News and Upcoming events - Providence

Upcoming Events

Press

Providence Medical Technology Announces New Equity Financing Of $10.5 Million

Global Healthcare Investor MVM Life Science Partners Leads Round.

Providence Medical Technology Announces the Publication of a Technique Paper

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical fusion technology, today announced the publication of “Novel instrumentation and technique for tissue sparing posterior cervical fusion” in the Journal of Clinical Neuroscience by Bruce McCormack, MD and Raman Dhawan, MD.

Providence Medical Technology Announces the Launch of CAVUX™ Cervical Cage-L and DTRAX® Spinal System-L

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical fusion technology, today announced the commercial launch of its new CAVUX Cervical Cage-L and DTRAX Spinal System-L.

Providence Medical Technology Announces Presentation of Two-Year Outcomes of Posterior Cervical Fusion for Single-Level Cervical Radiculopathy

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today announced the closing of $12 million in new financing for the company. The proceeds will be used to further commercialize and expand its portfolio of DTRAX® cervical fusion products designed to help patients suffering from cervical degenerative disc disease.

Providence Medical Technology Enhances Cervical Fusion Process With Introduction Of Proprietary Surface Technology to DTRAX Line of Tissue Sparing Devices

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today introduced its proprietary Cavux™ surface technology, designed to speed bone fusion during the healing process. The company’s portfolio of DTRAX® Cervical Cage implants will be available with Cavux, a unique surface technology that produces micro-textures on titanium surfaces. The micro- and nanotextures created across the implant surface area serve to enhance the fusion process.

Providence Medical Technology Launches DTRAX Bone Screws to U.S. Market

Providence Medical Technology, Inc. today announced the full commercial launch of DTRAX Bone Screws in the U.S. market.

Providence Medical Technology Raises $12 Million Through a Combination of Equity and Debt Financing

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today announced the closing of $12 million in new financing for the company. The proceeds will be used to further commercialize and expand its portfolio of DTRAX® cervical fusion products designed to help patients suffering from cervical degenerative disc disease.

Providence Medical Technology Granted CE Mark For Full DTRAX Line of Cervical Spine Products

Providence Medical Technology, Inc. announced today it has obtained a CE Mark for its DTRAX Spinal System, DTRAX Cervical Cage, and DTRAX Bone Screw. This regulatory approval expands the company’s international product offering to include its entire DTRAX portfolio.

Providence Medical Technology Announces Expansion of Patent Portfolio

Providence Medical Technology, Inc. today announced that the U.S. Patent and Trademark Office issued patents 8,834,530, Cervical Distraction Method; 8,834,472, Vertebral Joint Implants and Delivery Tools, and 8,828,062, Vertebral Joint Implants and Delivery Tools to the company in September 2014.

Providence Medical Technology Secures $3 Million Venture Debt Funding

Providence Medical Technology, Inc. announced today it has closed a $3 million venture debt agreement with East West Bank. The debt facility complements the $6.8 million venture funding that closed earlier in 2014.

Team | Innovation | Quality | Passion | Transparency
Copyright © 2022, Providence Medical Technology. All rights reserved.